Follow
Madhu Mazumdar
Madhu Mazumdar
Professor of Biostatistics, Icahn School of Medicine at Mount Sinai
Verified email at mountsinai.org - Homepage
Title
Cited by
Cited by
Year
An inflammatory cytokine signature predicts COVID-19 severity and survival
DM Del Valle, S Kim-Schulze, HH Huang, ND Beckmann, S Nirenberg, ...
Nature medicine 26 (10), 1636-1643, 2020
23282020
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma
RJ Motzer, M Mazumdar, J Bacik, W Berg, A Amsterdam, J Ferrara
Journal of clinical oncology 17 (8), 2530-2540, 1999
22141999
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma
RJ Motzer, J Bacik, BA Murphy, P Russo, M Mazumdar
Journal of clinical oncology 20 (1), 289-296, 2002
20612002
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma
RJ Motzer, J Bacik, LH Schwartz, V Reuter, P Russo, S Marion, ...
Journal of clinical oncology 22 (3), 454-463, 2004
9922004
DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia
ME Figueroa, S Lugthart, Y Li, C Erpelinck-Verschueren, X Deng, ...
Cancer cell 17 (1), 13-27, 2010
9702010
Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy
DF Bajorin, PM Dodd, M Mazumdar, M Fazzari, JA McCaffrey, HI Scher, ...
Journal of Clinical Oncology 17 (10), 3173-3181, 1999
8031999
Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion …
SM Larson, Y Erdi, T Akhurst, M Mazumdar, HA Macapinlac, RD Finn, ...
Clinical Positron Imaging 2 (3), 159-171, 1999
6911999
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
AB Siegel, EI Cohen, A Ocean, D Lehrer, A Goldenberg, JJ Knox, H Chen, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
5982008
Treatment outcome and survival associated with metastatic renal cell carcinoma of non–clear-cell histology
RJ Motzer, J Bacik, T Mariani, P Russo, M Mazumdar, V Reuter
Journal of Clinical Oncology 20 (9), 2376-2381, 2002
5692002
Perioperative comparative effectiveness of anesthetic technique in orthopedic patients
SG Memtsoudis, X Sun, YL Chiu, O Stundner, SS Liu, S Banerjee, ...
Anesthesiology 118 (5), 1046-1058, 2013
5662013
Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety
J Poeran, R Rasul, S Suzuki, T Danninger, M Mazumdar, M Opperer, ...
Bmj 349, 2014
5512014
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer
JG Guillem, DB Chessin, AM Cohen, J Shia, M Mazumdar, W Enker, ...
Annals of surgery 241 (5), 829-838, 2005
4942005
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA
S Worgall, D Sondhi, NR Hackett, B Kosofsky, MV Kekatpure, N Neyzi, ...
Human gene therapy 19 (5), 463-474, 2008
4672008
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
MW Kattan, MS Karpeh, M Mazumdar, MF Brennan
Journal of clinical oncology 21 (19), 3647-3650, 2003
4632003
Endoscopic pituitary surgery: a systematic review and meta-analysis
A Tabaee, VK Anand, Y Barrón, DH Hiltzik, SM Brown, A Kacker, ...
Journal of neurosurgery 111 (3), 545-554, 2009
4562009
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.
WK Kelly, HI Scher, M Mazumdar, V Vlamis, M Schwartz, SD Fossa
Journal of clinical oncology 11 (4), 607-615, 1993
4541993
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors
RJ Motzer, A Amsterdam, V Prieto, J Sheinfeld, V Murty, M Mazumdar, ...
The Journal of urology 159 (1), 133-138, 1998
4451998
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.
JA McCaffrey, S Hilton, M Mazumdar, S Sadan, WK Kelly, HI Scher, ...
Journal of Clinical Oncology 15 (5), 1853-1857, 1997
4321997
Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision‐making about cancer treatments
M Mazumdar, JR Glassman
Statistics in medicine 19 (1), 113-132, 2000
4152000
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for …
RJ Motzer, CJ Nichols, KA Margolin, J Bacik, PG Richardson, ...
Journal of Clinical Oncology 25 (3), 247-256, 2007
4042007
The system can't perform the operation now. Try again later.
Articles 1–20